3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Central Nervous System Neoplasms
36
Neuroblastoma
35
Brain Neoplasms
25
Medulloblastoma
22
Astrocytoma
10
Glioma
8
Glioblastoma
7
Choroid Plexus Neoplasms
7
Rhabdoid Tumor
6
Oligodendroglioma
6
Neuroectodermal Tumors, Primitive
6
Ependymoma
6
Breast Neoplasms
6
Sarcoma
5
Ovarian Neoplasms
5
Neoplasms
5
Ganglioneuroblastoma
5
Esthesioneuroblastoma, Olfactory
5
Carcinoma, Non-Small-Cell Lung
5
Testicular Neoplasms
4
Testicular Germ Cell Tumor
4
Small Cell Lung Carcinoma
4
Lung Neoplasms
4
Head and Neck Neoplasms
4
Gliosarcoma
4
Thyroid Neoplasms
3
Teratoma
3
Squamous Cell Carcinoma of Head and Neck
3
Seminoma
3
Endodermal Sinus Tumor
3
Interventions
Temozolomide
2
Oncolytic Virotherapy
2
vorasidenib
1
pembrolizumab
1
pamiparib
1
interferon gamma-1b
1
cixutumumab
1
Vorinostat
1
Vincristine
1
Valproic Acid
1
Thiotepa
1
Radiotherapy
1
Radiation
1
Peripheral Blood Stem Cell Transplantation
1
ONC206
1
Melphalan
1
Maintenance Chemotherapy
1
Lomustine
1
Interleukin-12
1
Interferon-gamma
1
Immunotherapy
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Erlotinib Hydrochloride
1
Cisplatin
1
Busulfan
1
Bone Marrow Transplantation
1
Antibodies, Monoclonal
1
Aminolevulinic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors
×
Cisplatin
×
CNS
×
Clear all
NCT01614132
2020-03-31
NOA-07
University of Regensburg
Phase 1/2
Completed
33 enrolled